dc.contributor.author |
Tselis, N |
en |
dc.contributor.author |
Ratka, M |
en |
dc.contributor.author |
Vogt, H |
en |
dc.contributor.author |
Kolotas, C |
en |
dc.contributor.author |
Baghi, M |
en |
dc.contributor.author |
Baltas, D |
en |
dc.contributor.author |
Fountzilas, G |
en |
dc.contributor.author |
Georgoulias, V |
en |
dc.contributor.author |
Ackermann, H |
en |
dc.contributor.author |
Zamboglou, N |
en |
dc.date.accessioned |
2014-03-01T02:01:09Z |
|
dc.date.available |
2014-03-01T02:01:09Z |
|
dc.date.issued |
2011 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/29161 |
|
dc.subject |
Computed Tomography |
en |
dc.subject |
Treatment Planning |
en |
dc.subject |
High Dose Rate |
en |
dc.subject |
Head and Neck Cancer |
en |
dc.subject |
Lymph Node |
en |
dc.title |
Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1016/j.radonc.2010.10.025 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1016/j.radonc.2010.10.025 |
en |
heal.publicationDate |
2011 |
en |
heal.abstract |
BackgroundDespite significant improvements in the treatment of head and neck cancer (HNC), lymph node recurrences remain a clinical challenge after primary radiotherapy. The value of interstitial (IRT) brachytherapy (BRT) for control of lymph node recurrence remains unclear. In order to clarify its role a retrospective review was undertaken on the value of computed tomography (CT)-guided IRT high-dose-rate (HDR)-BRT in isolated |
en |
heal.journalName |
Radiotherapy and Oncology |
en |
dc.identifier.doi |
10.1016/j.radonc.2010.10.025 |
en |